Clinical Trial Update: A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing lenalidomide and CC-486 with radiation therapy in patients with plasmacytoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasmacytoma
• Plasmacytoma of Bone

Drugs mentioned

• Onureg (azacitidine)
• Revlimid (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Plasmacytoma, Plasmacytoma of Bone | Phase 2 | Status: ACTIVE_NOT_RECRUITING